(5-Bromo-2-(trifluoromethoxy)phenyl)boronic acid, 95.0%, 1g

3-Ethylpyridin-4-amine hydrochloride, 500mg

1-(6-Chloro-5-(trifluoromethyl)pyridin-2-yl)piperazine, 95.0%, 250mg

N-Methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide, 95.0%, 5g

2-Amino-4-fluoro-5-methylbenzonitrile, 95+%, 1g

2-(Benzyloxy)-1-bromo-4-fluorobenzene, 95.0%, 25g

3,6-Dibromo-9-hexyl-9H-carbazole>98.0%(GC)1g

N,N'-Bis[4-di(m-tolyl)aminophenyl]-N,N'-diphenylbenzidine>98.0%(HPLC)1g

Ethyl 3-oxo-4-phenylbutanoate, 90.0%, 10g

5,6-Dimethyl-2-oxo-1,2-dihydropyridine-3-carbonitrile, 95.0%, 1g

3-Phenylpropionic Acid>98.0%(GC)(T)100g

Fmoc-N-(2,4,6-trimethoxybenzyl)-glycine, 97%, 1g

Phthalic acid, min. 99%, PA, 250 g, plastic packaging.